[Current treatment regimen in essential arterial hypertension]

Area of Science:

• Cardiology
• Pharmacology

Context:

• Arterial hypertension management is evolving.
• New drug classes like angiotensin-converting enzyme inhibitors and calcium channel blockers are influencing treatment paradigms.
• Extensive multicentric therapeutic trials provide evidence for revised clinical guidelines.

Purpose:

• To outline the anticipated changes in antihypertensive drug prescription.
• To highlight the shift from a "step-by-step" approach to personalized pharmacotherapy.
• To emphasize the potential benefits of individualized treatment strategies.

Summary:

• The future of arterial hypertension treatment involves abandoning the "step-by-step" method.
• Patients will receive personalized regimens with one or two highly selective drugs.
• This approach aims for better tolerability and improved patient compliance.

Impact:

• Personalized antihypertensive treatments are expected to be more effective.
• Improved compliance and targeted therapy will reduce cardiovascular morbidity and mortality.
• Addressing underlying pathologies like smoking and lipid disorders alongside hypertension will enhance treatment outcomes.